September 24, 2024
Biotechnology company RenovaCare Inc. has reached a $2 million deal to end a consolidated proposed class action alleging it pumped its stock prices by using a secret paid promotional campaign, the company's investors have told a New Jersey federal judge.
June 04, 2024
A New Jersey federal judge has ruled that investors in biotechnology company RenovaCare Inc. failed to prove their case against firms they accused of profiting from a scheme to pump up the company's shares, but otherwise allowed their claims to proceed against the maker of skin burn treatments and a few of its executives.
September 15, 2021
Pomerantz LLP, Hagens Berman Sobol Shapiro LLP, The Rosen Law Firm PA and Glancy Prongay & Murray LLP have launched competing bids to steer investors' two proposed class actions against biotechnology company RenovaCare Inc. in New Jersey federal court over claims the business unlawfully engaged in a stock promotion scheme.